Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Department of Pathology, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
World Neurosurg. 2022 Sep;165:e148-e158. doi: 10.1016/j.wneu.2022.05.115. Epub 2022 May 31.
Papillary craniopharyngioma (PCP) was previously believed to occur only in adults. Sporadic pediatric PCP (PPCP) confirmed by detection of BRAF V600E mutation has been reported since 2018, but is often misdiagnosed before being diagnosed definitively. We aimed to evaluate PPCP characteristics and propose diagnostic criteria for prompt diagnosis, seeking to reduce patient morbidity and mortality and reduce costs linked to misdiagnosis.
This study included 5 patients with PPCPs whose data were retrieved retrospectively from among 1032 patients with craniopharyngiomas admitted to Sanbo Brain Hospital Management Group from March 2017 to May 2021. Patients' demographics, clinical presentation, tumor imaging characteristics, histopathologic results, surgical approaches, and postoperative outcomes were analyzed.
PPCP was misdiagnosed intraoperatively as sellar abscess (n = 4) or Rathke cleft cyst (n = 1). Preoperative magnetic resonance imaging showed that all tumors were under the saddle diaphragm, and the cyst wall was enhanced (n = 5). Computed tomography scans showed scattered high-density signs (n = 4). No recurrence was noted after complete resection. Postoperative hypothalamic dysfunction was mild. BRAF V600E mutation was confirmed in all cases by sequencing and immunohistochemistry. Immunohistochemistry showed granulation and inflammation and MPO, CD3, CD20, CD38, CD68, and CD163 were positively expressed.
Misdiagnosis of PPCP is responsible for failed surgical treatment. We propose that prompt diagnosis of PPCP can be achieved if preoperative magnetic resonance images show the tumor under saddle diaphragm with tumor wall enhancement and computed tomography scans show high-density signs scattered in the tumor, which leads to safe, effective tumor resection. Our proposed diagnosis and treatment strategy for PPCP reduces morbidity and mortality.
此前认为颅咽管瘤(PCP)仅发生于成年人。自 2018 年以来,已报道了 BRAF V600E 突变证实的散发性小儿颅咽管瘤(PPCP),但在明确诊断之前,往往被误诊。我们旨在评估 PPCP 的特征,并提出有助于及时诊断的诊断标准,以期降低患者的发病率和死亡率,并降低误诊相关的费用。
本研究纳入了 5 例 PPCP 患者,这些患者的数据是从 2017 年 3 月至 2021 年 5 月期间 Sanbo 脑科医院管理集团收治的 1032 例颅咽管瘤患者中回顾性检索得到的。分析了患者的人口统计学、临床表现、肿瘤影像学特征、组织病理学结果、手术方法和术后转归。
PPCP 术中误诊为鞍隔下脓肿(n=4)或 Rathke 裂囊肿(n=1)。术前磁共振成像(MRI)显示所有肿瘤均位于鞍膈下,囊壁增强(n=5)。计算机断层扫描(CT)显示散在高密度征象(n=4)。完全切除后无复发。术后下丘脑功能障碍较轻。所有病例均通过测序和免疫组化证实存在 BRAF V600E 突变。免疫组化显示肉芽组织和炎症,且 MPO、CD3、CD20、CD38、CD68 和 CD163 阳性表达。
PPCP 的误诊导致手术治疗失败。我们建议,如果术前 MRI 显示肿瘤位于鞍膈下且肿瘤壁增强,CT 扫描显示肿瘤内散在高密度征象,则可及时诊断 PPCP,从而实现安全、有效的肿瘤切除。我们提出的 PPCP 诊断和治疗策略降低了发病率和死亡率。